PPT-Ovarian Cancer

Ovarian Cancer Epithelial Tumor postmenopausal women Germ cell younger women Sex cordstromal origin any age Approximately 90 of ovarian cancer is epithelial significant therapeutic challenges . Arkansas Statistics. Nancy Andrews Collins, M.D., MBA. Associate Professor. Department of Obstetrics and Gynecology. College of Medicine. University of Arkansas for Medical Sciences (UAMS). Ovarian Cancer. in . Primary Care. When to refer?. Physiological/pathological. Benign/malignant. Surgical approach?. . Open or keyhole?. Do I need to do anything?. . Conservative or active . Mx. Learning Points. Talking point:. Genetics of ovarian cancer. 49F. Underwent risk-reduction surgery. Total hysterectomy and bilateral . salpingo. -oophorectomy. Significant family history . Sister passed away in her 40s due to breast cancer. Rob . Gornall. Consultant Gynaecology. GHNHST. How do we benchmark ourselves?. Survival. Stage at presentation. Audit against agreed referral guidelines. Are pathways agreed fit for purpose?. What information/resource is there . PCB = Carcinoma of the Cervix. Abdominal Distension Age > 50 years = Ovarian Cancer. Vulval. Ulceration Age > 60 years = . Vulval. Cancer. Government Pledges on Waiting Times. Maximum Duration of Waiting:. BRCA1 and BRCA2. Jennifer . Hardee. Normal function of the genes. BRCA1 & BRCA2 are in the same DNA repair pathway. Despite names, do not share any protein structure. Both are . tumor suppressors . Improvement in 5 Year Survival:. Race. 1975. 1989. 2014. All. 36%. 38%. 47%. White. 35%. 38%. 48%. African American. 42%. 34%. 39%. Noone. AM, . Howlader. N, . Krapcho. M, et al. (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute, Bethesda, MD, www.seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website April 2018.. th. most incident and lethal cancer. New cases: 225,000 annually. Deaths: 140,000 annually. *Almost 75% of cases present with advanced stage .. *Risk of relapse of advanced stage disease is as high as 70%. Women's Health Initiative. About Ovarian Cancer. Cance. r starts when cells in the body begin to grow out of control. Ovarian cancer tumors may start in fallopian tubes than in ovaries. Ovaries are made of 3 kinds of cells, each can develop into a different type of tumor. Pathway Guide – Ovarian cysts: General Information| Saint Mary’s Lead: Dr Ursula Winters & Dr Rohit Arora | v1.0 | Created: 03/02/21. Knowing the options. When a scan report is received indicating an ovarian cyst, there are only three options for further management which are to repeat, to reassure, or to refer (either routine or urgent). Most scan reports will include management advice based on the following pathways. When reviewing a scan result, patients should be managed according to their fertility status: Pregnant, Pre-menopausal, and . 1 The Facts Ovarian cancer is the fourth most common cancer in women. Each year about 400 women are diagnosed with ovarian cancer in Ireland. The symptoms can be very vague, particularly when the d Stuart Salfinger. Gynaecologic Oncologist. MBBS, FRANZCOG, CGO, Dip . Surg. Ed. Ovarian Carcinoma. Leading cause fatality gynaecologic cancer. Incidence 1.5% lifetime risk. 75% present stage 3+. Stage 3 disease 30% 5 year survival. granulosa. cell . tumours. Jo Moffatt ST4. Claire Newton. St Michael’s Hospital, Bristol. Background. Aims and methods. Results. Conclusions. Adult . granulosa. cell . tumours. Type of sex cord stromal . introduction. S. econd most common gynecologic malignancy.. I. n . developed countries, . the incidence . of 9.4 per 100,000 women and a mortality rate of 5.1 per 100,000.. In developing countries, it is the third most common gynecologic malignancy (cervical cancer is the most common), with an incidence of 5.0 per 100,000 and a mortality rate of 3.1 per 100,000. .